|
TOP2A
|
topoisomerase (DNA) II alpha 170 kDa
|
2.91
|
0.013
|
|
CDKN3
|
cyclin-dependent kinase inhibitor 3
|
2.64
|
0.010
|
|
ARHGAP11A
|
Rho GTPase activating protein 11A
|
2.61
|
0.029
|
|
STMN1
|
stathmin 1
|
2.57
|
0.015
|
|
ECT2
|
epithelial cell transforming sequence 2 oncogene
|
2.53
|
0.023
|
|
DEPDC1
|
DEP domain containing 1
|
2.51
|
0.015
|
|
CENPA
|
centromere protein A
|
2.49
|
0.006
|
|
CENPF
|
centromere protein F, 350/400 kDa (mitosin)
|
2.45
|
0.017
|
|
CKAP2
|
cytoskeleton associated protein 2
|
2.39
|
0.024
|
|
PRR11
|
proline rich 11
|
2.32
|
0.036
|
|
KIF11
|
kinesin family member 11
|
2.25
|
0.007
|
|
KIF20A
|
kinesin family member 20A
|
2.21
|
0.017
|
|
BUB1B
|
budding uninhibited by benzimidazoles 1 homolog beta
|
2.20
|
0.004
|
|
LOC618147
|
histone cluster 1, H2ai-like
|
2.17
|
0.002
|
|
KIF4A
|
kinesin family member 4A
|
2.13
|
0.018
|
|
LOC787465
|
histone H2B type 1-like
|
2.10
|
0.006
|
|
GAS2L3
|
growth arrest-specific 2 like 3
|
1.99
|
0.018
|
|
SMC4
|
structural maintenance of chromosomes 4
|
1.98
|
0.011
|
|
SMC2
|
structural maintenance of chromosomes 2
|
1.96
|
0.011
|
|
RRM2
|
ribonucleotide reductase M2
|
1.95
|
0.046
|
|
CASC5
|
cancer susceptibility candidate 5
|
1.93
|
0.029
|
|
ESCO2
|
establishment of cohesion 1 homolog 2
|
1.93
|
0.032
|
|
HIST2H2BF
|
histone cluster 2, H2bf
|
1.91
|
0.039
|
|
HELLS
|
helicase, lymphoid-specific
|
1.90
|
0.013
|
